cGMP Pilot Plant
/userfiles/images/api/pati/3.jpg)
Cutting edge technologies, FDA approved
Number of Employees:
17
Design temperature ranges:
-20° to +150° C
Capacity:
50L up to 1600L
Safety & Precautions
HVAC system to optimize the number of air exchanges to maintain both the necessary level of cleanliness (ISO 8 for product isolation area) and the limiting of the risk of explosion. A dedusting system is utilized with local exhaust hoods in order into provide the required level of containment.
Compliance with the current GMP guideline.
State-of-the-art techniques
and practices:
and practices:
Main equipment:/userfiles/images/api/pati/4.jpg)
- Two glass-lined vessels of 100L and 250L with reflux condensers
- One stainless steel vessel of 500L
- Three glass-lined crystallizers of 100L, 250L and 500L
- One movable stainless steel reactor of 150L
- One Nutch filter in stainless steel (600mm in diameter)
- One centrifuge, vertical axis of 800L
- One tray dryer with 10 trays providing a total surface of 14 sqm
- One granulator (flake crusher) with screen mesh ranging from 0.1 mm to 1.00 mm
- One micronizer with capacity ranging from 0.5 kg/h to 5.0 kg/h
- Two syl-oil cooling/heating skids with temperature control in the range of ±1°C
Latest news
CEP for Baclofen available
Monday, 02-01-2012
Polpharma has been granted Certificate of Suitability (CEP) by the European Directorate for the Quality of...
Polpharma – the most innovative company in Poland
Friday, 20-05-2011
Polpharma ranked first as the most innovative company in Poland, in a research study run by the Institute...
Polpharma has inaugurated a new state of the art 300 sq.m. Process Development Labs complex
Friday, 08-10-2010
Polpharma has inaugurated a new state of the art 300 sq.m. Process Development Labs complex for the...
Co-operation between Polpharma and RPG Life Sciences
Tuesday, 05-10-2010
RPGLS and Polpharma announced their co-operation in the development and manufacture of Active...